Male and female brain tumor cells feed themselves differently
Original title: Sex differences in glycine biosynthesis drives sex-specific responses to combined nutrient deprivation and pharmacological inhibition in brain tumors.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was done only in mouse tumor cells in a lab.
The short version
In lab tests, male and female brain tumor cells did not react the same way to a drug that blocks a key nutrient.
What was studied. Researchers used brain tumor cells from a mouse model of glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary. They blocked the cells' ability to make glycine, a small building block the cells use to grow. They also took glycine and related nutrients out of the cells' food.
What they found. Male tumor cells made more of their own glycine than female cells did. Male cells also reacted more strongly when the drug blocked that process in food rich conditions. Taking glycine or related nutrients out of the food made the drug work better in both male and female cells.
What this means, and what it doesn't
What it could mean: Sex may matter in how brain tumors feed themselves. That could someday shape how drugs are chosen or tested. The authors hope to study a drug paired with a low glycine diet.
What it doesn't mean: This is not a new treatment. The work was done in mouse tumor cells in a lab, not in people. No one knows yet if it helps patients. It is not a cure, and no doctor can offer it today. Do not change your diet because of this study.
Source: PubMed, September 22, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.